Financial Advocates Investment Management Baxter International Inc Transaction History

Financial Advocates Investment Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 08, 2019	SELL	$73.44 - $82.41 $228,031 - $255,883	-3,105 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$64.48 - $81.31 $355,091 - $447,774	-5,507 Reduced 63.95%	3,105 $252,000
Q4 2018 Mar 04, 2019	BUY	$61.45 - $77.8 $393,157 - $497,764	6,398 Added 288.98%	8,612 $263,000
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $3,195 - $4,045	-52 Reduced 2.29%	2,214 $145,000
Q3 2018 Nov 14, 2018	BUY	$70.71 - $77.75 $160,228 - $176,181	2,266 New	2,266 $0

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.